ODI Pharma AB6OD 
$0.20-13.30%24h
-13.30%24h
Global rank33369
Market cap$3.00M
Change 7d-13.30%
YTD Performance-54.78%
SP500 benchmarkUnderperform
P/E-0.43
P/S239.55
Revenue$12.52K
Earnings-$619.75K
Dividend yield-
Main Sector
Healthcare
ODI Pharma AB (6OD) Stock Overview
ODI Pharma AB (publ), a pharmaceutical company, produces and distributes pharmaceutical cannabis and cosmetics products in Europe. The company offers cannabidiol-infused facial cream, facial mask, and body balm under the Kandol. brand name through kandol.net. The company was founded in 2018 and is based in Stockholm, Sweden.
6OD Stock Information
Symbol
6ODAddress
Östermalmstorg 1Stockholm, 114 42Sweden
Founded
-Trading hours
-Website
https://www.odipharma.comCountry
🇸🇪 SwedenPhone Number
ODI Pharma AB (6OD) Price Chart
-
Value:-
ODI Pharma AB Overview: Key Details and Summary
Stock data | 2023 | Change |
|---|---|---|
| Price | $0.19562179988223152 | N/A |
| Market Cap | $3.00M | N/A |
| Shares Outstanding | 15.34M | 1.69% |
| Employees | 1.00 | N/A |
| Shareholder Equity | 2.57M | -72.22% |
Valuation | 2023 | Change |
|---|---|---|
| P/E Ratio | -0.43 | N/A |
| P/S Ratio | 239.55 | N/A |
| P/B Ratio | 1.17 | N/A |
Growth | 2023 | Change |
|---|---|---|
| Return on Equity | -0.2409 | N/A |
Earnings | 2023 | Change |
|---|---|---|
| Revenue | $12.52K | N/A |
| Earnings | -$619.75K | N/A |
| EPS | -0.45 | N/A |
| Earnings Yield | -2.30 | N/A |
| Gross Margin | -5.15 | N/A |
| Operating Margin | -48.84 | N/A |
| Net income margin | -49.49 | N/A |
Financial Strength | 2023 | Change |
|---|---|---|
| Total Assets | $735.09K | N/A |
| Cash on Hand | $583.08K | N/A |
| Debt to Equity | 0.1959 | 1535.26% |
| Current Ratio | $1.46 | -82.83% |
